[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Role of Uric Acid in Multiple Sclerosis

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Multiple Sclerosis Genetics

✍ Rodriguez, Moses 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 263 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Immunological Aspects of Axon Injury in Multiple Sclerosis

✍ Rodriguez, Moses 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 296 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Remyelination in Experimental Models of Toxin-Induced Demyelination

✍ Rodriguez, Moses 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 582 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease

✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease

✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Advances in Experimental Medicine and B

[Advances in Experimental Medicine and Biology] Neurodegenerative Diseases Volume 724 || Multiple Sclerosis

✍ Ahmad, Shamim I. 📂 Article 📅 2012 🏛 Springer US ⚖ 304 KB

[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || Role of Uric Acid in Multiple Sclerosis

✦ Synopsis